Total Payments
$13,229
2024 Payments
$2,196
Companies
56
Transactions
874
Medicare Patients
4,765
Medicare Billing
$266,714
Payment Breakdown by Category
Food & Beverage$13,220 (99.9%)
Education$8.35 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,220 | 873 | 99.9% |
| Education | $8.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,464 | 40 | $0 (2024) |
| ABBVIE INC. | $1,407 | 81 | $0 (2024) |
| Novo Nordisk Inc | $1,162 | 78 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,156 | 92 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $935.03 | 49 | $0 (2024) |
| Lilly USA, LLC | $918.83 | 87 | $0 (2024) |
| PFIZER INC. | $838.59 | 86 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $543.65 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $463.53 | 48 | $0 (2022) |
| Amgen Inc. | $458.82 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,196 | 112 | ABBVIE INC. ($357.32) |
| 2023 | $2,067 | 121 | ABBVIE INC. ($444.19) |
| 2022 | $1,743 | 105 | ABBVIE INC. ($198.20) |
| 2021 | $1,277 | 76 | AbbVie Inc. ($309.35) |
| 2020 | $534.19 | 26 | AstraZeneca Pharmaceuticals LP ($214.38) |
| 2019 | $1,816 | 128 | SANOFI-AVENTIS U.S. LLC ($286.21) |
| 2018 | $1,929 | 152 | AstraZeneca Pharmaceuticals LP ($315.29) |
| 2017 | $1,665 | 154 | AstraZeneca Pharmaceuticals LP ($247.79) |
All Payment Transactions
874 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.00 | General |
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: PAIN | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.79 | General |
| Category: Cardiovascular | ||||||
| 10/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Automated insulin delivery system | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 967 | 1,313 | $203,998 | $47,542 |
| 2022 | 21 | 1,268 | 1,700 | $246,090 | $59,513 |
| 2021 | 23 | 1,334 | 1,824 | $236,698 | $90,642 |
| 2020 | 18 | 1,196 | 1,595 | $200,488 | $69,016 |
Total Patients
4,765
Total Services
6,432
Medicare Billing
$266,714
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 450 | $81,000 | $18,151 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 263 | $35,505 | $10,378 | 29.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 67 | 68 | $7,480 | $4,799 | 64.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,350 | $3,946 | 53.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 75 | $2,850 | $2,116 | 74.3% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 51 | 52 | $4,680 | $1,944 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 133 | 133 | $36,575 | $1,284 | 3.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 119 | $2,737 | $1,096 | 40.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $6,900 | $997.00 | 14.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 22 | $10,230 | $843.70 | 8.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $4,275 | $627.24 | 14.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 15 | 15 | $1,650 | $484.68 | 29.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $532.00 | $400.40 | 75.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 40 | $2,000 | $369.25 | 18.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 13 | $234.00 | $105.20 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 526 | $93,014 | $20,851 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 213 | 301 | $38,827 | $11,338 | 29.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 96 | 97 | $10,670 | $6,639 | 62.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $7,198 | $3,634 | 50.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 103 | 104 | $3,952 | $2,804 | 71.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 54 | 54 | $4,860 | $1,925 | 39.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 48 | 48 | $4,320 | $1,652 | 38.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,240 | $1,600 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 175 | 175 | $47,342 | $1,473 | 3.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 29 | $13,080 | $1,458 | 11.1% |
About Dr. Douglas Goderwis, MD
Dr. Douglas Goderwis, MD is a Pediatrics healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760439095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Goderwis, MD has received a total of $13,229 in payments from pharmaceutical and medical device companies, with $2,196 received in 2024. These payments were reported across 874 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,220).
As a Medicare-enrolled provider, Goderwis has provided services to 4,765 Medicare beneficiaries, totaling 6,432 services with total Medicare billing of $266,714. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Florence, KY
- Active Since 05/30/2006
- Last Updated 05/02/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1760439095
Products in Payments
- FARXIGA (Drug) $1,153
- VRAYLAR (Drug) $963.51
- TRELEGY ELLIPTA (Drug) $807.48
- JARDIANCE (Drug) $401.08
- XARELTO (Drug) $362.13
- Ozempic (Drug) $325.39
- SOLIQUA 100/33 (Biological) $263.06
- TRULICITY (Drug) $260.98
- UBRELVY (Drug) $253.71
- TOUJEO (Drug) $252.37
- Aimovig (Biological) $248.84
- GEMTESA (Drug) $233.99
- Kerendia (Drug) $229.89
- EMGALITY (Drug) $223.55
- REXULTI (Drug) $218.89
- XIFAXAN (Drug) $215.32
- Wegovy (Drug) $213.78
- MOUNJARO (Drug) $204.06
- CHANTIX (Drug) $190.84
- QELBREE (Drug) $189.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Florence
Dr. Amanda Bruemmer, M.d, M.D
Pediatrics — Payments: $4,771
Pediatrics $4,771
Brandie Chan, M.d, M.D
Pediatrics — Payments: $4,374
Pediatrics $4,374
John Lacount, Md, MD
Pediatrics — Payments: $4,259
Pediatrics $4,259
Dr. Judy Moore, M.d, M.D
Pediatrics — Payments: $3,454
Pediatrics $3,454
Dr. Douglas Poon, M.d, M.D
Pediatrics — Payments: $2,843
Pediatrics $2,843
Jaclyn Anderson, Md, MD
Pediatrics — Payments: $2,558
Pediatrics $2,558